Adverse Drug Reactions Monitoring

Patients with cardiovascular disease are particularly vulnerable to adverse drug reactions (ADRs). ADR occur frequently in modern medical practice, increasing mortality and morbidity and inflating the cost of care. Patients with cardiovascular disease are vulnerable due to their polypharmacy, advanced age, and the influence of heart disease on drug metabolism. The ADR potential for a particular cardiovascular drug varies the extent of exposure to other drugs, the disease being treated, and the individual.

 

  • World Health Organization (WHO)
  • International Conference on Harmonization (ICH)
  • Suspected ADR reporting forms
  • Individual Case Safety Reports

Related Conference of Adverse Drug Reactions Monitoring

May 30-31, 2024

6th Euro Cardiology Congress

Vienna, Austria
May 30-31, 2024

39th World Congress on Heart Diseases

Vienna, Austria
June 20-21, 2024

5th European Summit on Cardiology Research

Dublin, Ireland
July 16-17, 2024

13th World Heart Congress

Paris, France
August 01-02, 2024

38th World Congress on Heart Diseases

Montreal, Canada
September 16-17, 2024

3rd Global Summit on Cardiology and Cardiac Surgery

Paris, France
October 24-25, 2024

11th International Conference on Interventional Cardiology

Zurich, Switzerland
October 30-31, 2024

7th Global Cardiovascular Research and Clinical Cardiology

Vancouver, Canada

Adverse Drug Reactions Monitoring Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in